EBV IgG antibody to Early Antigen near me in Chandigarh

The EBV IgG antibody to Early Antigen measures the presence of Immunoglobulin G (IgG) antibodies directed against the Early Antigen (EA) complex of the Epstein-Barr Virus. These antibodies typically appear during the early phase of infection, shortly after the initial immune response begins. Unlike IgM antibodies, which rise quickly and decline within weeks, EBV-EA IgG antibodies develop slightly later but usually remain detectable for a few months.

In most cases, EBV-EA IgG antibodies often decline within a few months (commonly 3–6 months) after the primary infection resolves, suggesting reduced viral activity. However, in some individuals, these antibodies may persist for longer periods or reappear at elevated levels if the virus reactivates later, particularly during immune suppression, often suggests reduced active viral activity.

Therefore, the presence of EBV-EA IgG antibodies may suggest a recent or active EBV infection or viral reactivation, rather than a past, fully resolved infection. This helps differentiate it from EBV-VCA IgG antibodies, which usually appear later and typically remain positive for life, indicating past exposure. However, results should always be interpreted together with other EBV markers (such as VCA IgM, VCA IgG, and EBNA IgG) and the person’s symptoms for accurate clinical evaluation.